ERAS-601 for chordoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Apr 2025: Trial started, NCT06957327
  2. 4 May 2025: Trial registered, NCT06957327

The trials

NCT06957327: A Study of ERAS-601 in People With Chordoma

State
Under way
Phase
Phase 1 and Phase 2
People
12 taking part
Started
25 Apr 2025
Primary completion
Apr 2027
Arms
ERAS-601
Results
None posted
  1. 25 Apr 2025: Trial started
  2. 4 May 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.